Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus iGlarLixi In Italy

• मुख्य लेखकों: Pöhlmann J (लेखक), Montagnoli R (लेखक), Lastoria G (लेखक), Parekh W (लेखक), Markert M (लेखक), Hunt B (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Dove Medical Press, 2019-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Johannes Pöhlmann,1 Roberta Montagnoli,2 Giusi Lastoria,3 Witesh Parekh,4 Marie Markert,5 Barnaby Hunt1 1Health Economics, Ossian Health Economics and Communications, Basel 4051, Switzerland; 2External Affairs-Region Europe, Novo Nordisk SpA, Rome IT00144, Italy; 3Medical Advice, Novo Nordisk SpA, R...